These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 923186)

  • 1. Effectiveness of prednisolone during phenytoin therapy.
    Petereit LB; Meikle AW
    Clin Pharmacol Ther; 1977 Dec; 22(6):912-6. PubMed ID: 923186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of administration of estrogen or diphenylhydantoin on the kinetics of diphenylhydantoin in man.
    Fernandez-Pol JA; Zaninovich AA
    J Nucl Med; 1975 Apr; 16(4):305-8. PubMed ID: 803558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of phenytoin and phenobarbital on the disposition of a single oral dose of clonazepam.
    Khoo KC; Mendels J; Rothbart M; Garland WA; Colburn WA; Min BH; Lucek R; Carbone JJ; Boxenbaum HG; Kaplan SA
    Clin Pharmacol Ther; 1980 Sep; 28(3):368-75. PubMed ID: 7408397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetanilide and paracetamol pharmacokinetics before and during phenytoin administration: genetic control of induction?
    Cunningham JL; Evans DA
    Br J Clin Pharmacol; 1981 Jan; 11(6):591-5. PubMed ID: 7272175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenytoin modulates the pharmacokinetics of prednisolone and the pharmacodynamics of prednisolone as assessed by the inhibition of the mixed lymphocyte reaction in humans.
    Frey BM; Frey FJ
    Eur J Clin Invest; 1984 Feb; 14(1):1-6. PubMed ID: 6230241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of phenytoin (diphenylhydantoin) on the extrathyroidal turnover of thyroxine, 3,5,3'-triiodothyronine, 3,3',5'-triiodothyronine, and 3',5'-diiodothyronine in man.
    Faber J; Lumholtz IB; Kirkegaard C; Poulsen S; Jørgensen PH; Siersbaek-Nielsen K; Friis T
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1093-9. PubMed ID: 4055984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of four brands of phenytoin tablets.
    Pentikäinen PJ; Neuvonen PJ; Elfving SM
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):213-8. PubMed ID: 1243985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prednisolone and methylprednisolone kinetics in children receiving anticonvulsant therapy.
    Bartoszek M; Brenner AM; Szefler SJ
    Clin Pharmacol Ther; 1987 Oct; 42(4):424-32. PubMed ID: 3665340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of disulfiram on the half life and metabolic clearance rate of diphenylhydantoin and tolbtamide in man.
    Svendsen TL; Kristensen MB; Hansen JM; Skovsted L
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):439-41. PubMed ID: 971708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting the bioavailability of phenytoin.
    Neuvonen PJ; Pentikäinen PJ; Elfving SM
    Int J Clin Pharmacol Biopharm; 1977 Feb; 15(2):84-9. PubMed ID: 577918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excretion of phenytoin into semen of rabbits and man. Comparison with plasma levels.
    Swanson BN; Leger RM; Gordon WP; Lynn RK; Gerber N
    Drug Metab Dispos; 1978; 6(1):70-4. PubMed ID: 23276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration.
    Täuber U; Haack D; Nieuweboer B; Kloss G; Vecsei P; Wendt H
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):48-55. PubMed ID: 6698661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortisol does not inhibit prednisolone clearance.
    Meffin PJ; Sallustio BC; Purdie YJ; Robson RA; Wing LM; Brooks PM
    Br J Clin Pharmacol; 1985 Oct; 20(4):414-6. PubMed ID: 4074609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative drug elimination in man-diphenylhydantoin and amobarbital.
    Brien JF; Inaba T; Kalow W
    Eur J Clin Pharmacol; 1975 Oct; 9(1):79-83. PubMed ID: 1233257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma level studies on different brands of sodium diphenylhydantoin (DPH) and primidone.
    Borst SI; Lockwood CH
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):309-14. PubMed ID: 1242131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentrations of 5-(4-hydroxyphenyl)-5-phenylhydantoin in phenytoin-treated patients.
    Hoppel C; Garle M; Rane A; Sjöqvist F
    Clin Pharmacol Ther; 1977 Mar; 21(3):294-300. PubMed ID: 837648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone and prednisolone in the horse: pharmacokinetics and action on the adrenal gland.
    Toutain PL; Brandon RA; de Pomyers H; Alvinerie M; Baggot JD
    Am J Vet Res; 1984 Sep; 45(9):1750-6. PubMed ID: 6497132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of diphenylhydantoin on cortisol kinetics in humans.
    Choi Y; Thrasher K; Werk EE; Sholiton LJ; Olinger C
    J Pharmacol Exp Ther; 1971 Jan; 176(1):27-34. PubMed ID: 4936459
    [No Abstract]   [Full Text] [Related]  

  • 19. Monitoring prednisone and prednisolone.
    Jusko WJ; Rose JQ
    Ther Drug Monit; 1980; 2(2):169-76. PubMed ID: 6762710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of diphenylhydantoin (phenytoin) on the sequential stages of intestinal folate absorption.
    Nelson EW; Crick WF; Cerda JJ; Wilder BJ; Streiff RR
    Drug Nutr Interact; 1983; 2(1):47-56. PubMed ID: 6689591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.